荃信生物-B(02509)11月19日斥资199.62万港元回购9.72万股
Qyuns TherapeuticsQyuns Therapeutics(HK:02509) 智通财经网·2025-11-19 14:02

Group 1 - The company, Zhenxin Biotechnology-B (02509), announced a share buyback plan on November 19, 2025, involving an expenditure of HKD 1.9962 million to repurchase 97,200 H-shares at a price range of HKD 20.38 to HKD 20.70 per share [1]